Warren Stone - Dec 1, 2023 Form 4 Insider Report for NEOGENOMICS INC (NEO)

Role
President, Clinical Services
Signature
/s/ Ali Olivo, Attorney-in-Fact
Stock symbol
NEO
Transactions as of
Dec 1, 2023
Transactions value $
$0
Form type
4
Date filed
12/5/2023, 04:49 PM
Previous filing
May 15, 2023
Next filing
Feb 27, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NEO Common Stock Tax liability $0 -5.43K -6.09% $0.00 83.8K Dec 1, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding NEO Stock Option (Right to Buy) 166K Dec 1, 2023 Common Stock 166K $11.21 Direct F2
holding NEO Stock Option (Right to Buy) 54K Dec 1, 2023 Common Stock 54K $19.65 Direct F3
holding NEO Restricted Stock Unit 28.8K Dec 1, 2023 Common Stock 28.8K $0.00 Direct F4, F5
holding NEO Performance Stock Unit 21.2K Dec 1, 2023 Common Stock 21.2K $0.00 Direct F5, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares surrendered to NeoGenomics Inc. for retirement to satisfy the tax obligations in connection with the December 1, 2023 vesting of restricted stock.
F2 On December 1, 2022, Mr. Stone was granted 166,113 stock options. These options vest ratably over the first four anniversary dates of the grant date.
F3 On May 11, 2023, Mr. Stone was granted 53,969 stock options. These options vest ratably over the first three anniversary dates of the grant date.
F4 On May 11, 2023, Mr. Stone was granted 28,838 restricted stock units. These restricted stock units vest ratably over the first three anniversary dates of the grant date.
F5 Once vested, the shares of common stock are not subject to expiration.
F6 On May 11, 2023, Mr. Stone was granted 21,204 performance stock units representing the number of shares that may vest at target performance. The maximum number of shares that may vest pursuant to the performance criteria is 31,806. The number of performance stock units that may vest is based on the achievement of certain share growth goals based on the weighted average price of the Company's common stock over the 20-day trailing trading period at the applicable measurement dates, subject to continued service with the Company.